{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:55:16Z","timestamp":1788368116619,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biophysical Chemistry"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bpc.2026.107638","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T23:17:16Z","timestamp":1776467836000},"page":"107638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["In silico QSAR-guided design of Dammarane-type triterpenoids as potential PI3K\u03b1-targeted anticancer agents"],"prefix":"10.1016","volume":"335","author":[{"given":"Mouad","family":"Lahyaoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"El Yaqoubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajar","family":"Lahyaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafsa","family":"El Idrissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taoufiq","family":"Saffaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bouchaib","family":"Ihssane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riham","family":"Sghyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada Kheira","family":"Sebbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef Kandri","family":"Rodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpc.2026.107638_bb0005","series-title":"Cancer and Surrounding Environment: Etiologies and Tumor Microenvironment","first-page":"303","article-title":"A global perspective of cancer prevalence: The causative agent, the environment, or the genes","author":"Mohamed","year":"2025"},{"issue":"5","key":"10.1016\/j.bpc.2026.107638_bb0010","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bpc.2026.107638_bb0015","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","article-title":"The PI3K pathway in human disease","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bpc.2026.107638_bb0020","series-title":"Phosphoinositide 3-kinase in Health and Disease: Volume 2","first-page":"21","article-title":"Oncogenic mutations of PIK3CA in human cancers","author":"Samuels","year":"2010"},{"issue":"1","key":"10.1016\/j.bpc.2026.107638_bb0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrc3860","article-title":"PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting","volume":"15","author":"Thorpe","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.bpc.2026.107638_bb0030","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J. Nat. Prod."},{"issue":"6","key":"10.1016\/j.bpc.2026.107638_bb0035","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrd3137","article-title":"Targeting mitochondria for cancer therapy","volume":"9","author":"Fulda","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.bpc.2026.107638_bb0040","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.3390\/molecules25071649","article-title":"Chemistry, biological activities and in silico bioprospection of sterols and triterpenes from Mexican columnar Cactaceae","volume":"25","author":"Salazar","year":"2020","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.bpc.2026.107638_bb0045","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0378-8741(95)90032-2","article-title":"Pharmacology of oleanolic acid and ursolic acid","volume":"49","author":"Liu","year":"1995","journal-title":"J. Ethnopharmacol."},{"issue":"7","key":"10.1016\/j.bpc.2026.107638_bb0050","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1517\/13543776.2015.1038239","article-title":"Dammarane triterpenoids for pharmaceutical use: a patent review (2005\u20132014)","volume":"25","author":"Cao","year":"2015","journal-title":"Exp. Opin. Ther. Pat."},{"issue":"8","key":"10.1016\/j.bpc.2026.107638_bb0055","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1021\/ja01062a035","article-title":"p-\u03c3-\u03c0 analysis. A method for the correlation of biological activity and chemical structure","volume":"86","author":"Hansch","year":"1964","journal-title":"J. Am. Chem. Soc."},{"issue":"5","key":"10.1016\/j.bpc.2026.107638_bb0060","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/qsar.200610151","article-title":"Principles of QSAR models validation: internal and external","volume":"26","author":"Gramatica","year":"2007","journal-title":"QSAR Comb. Sci."},{"issue":"1\u20133","key":"10.1016\/j.bpc.2026.107638_bb0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.bpc.2026.107638_bb0070","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrd1032","article-title":"ADMET in silico modelling: towards prediction paradise","volume":"2","author":"Van De Waterbeemd","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"issue":"16","key":"10.1016\/j.bpc.2026.107638_bb0075","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"2","key":"10.1016\/j.bpc.2026.107638_bb0080","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12551-016-0247-1","article-title":"Software for molecular docking: a review","volume":"9","author":"Pagadala","year":"2017","journal-title":"Biophys. Rev."},{"issue":"1","key":"10.1016\/j.bpc.2026.107638_bb0085","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/sj.bjp.0707306","article-title":"In silico pharmacology for drug discovery: applications to targets and beyond","volume":"152","author":"Ekins","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bpc.2026.107638_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111964","article-title":"Synthesis and anti-cancer activity studies of Dammarane-type triterpenoid derivatives","volume":"187","author":"Ma","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bpc.2026.107638_bb0095","series-title":"Recent Advances in QSAR Studies: Methods and Applications","first-page":"29","article-title":"Molecular descriptors","author":"Consonni","year":"2009"},{"key":"10.1016\/j.bpc.2026.107638_bb0100","series-title":"Design of Experiments: Principles and Applications","author":"Eriksson","year":"2008"},{"issue":"12","key":"10.1016\/j.bpc.2026.107638_bb0105","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1021\/jm4004285","article-title":"QSAR modeling","volume":"57","author":"Cherkasov","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bpc.2026.107638_bb0110","first-page":"641","article-title":"Quantum chemical descriptors in QSAR","author":"Karelson","year":"2004","journal-title":"Comp. Med. Chem. Drug Discov."},{"key":"10.1016\/j.bpc.2026.107638_bb0115","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/vjch.202000221","article-title":"Synthesis of new 3-(hydroxymethyl)-2-phenyl-2,3-dihydroquinolinone and in-silico evaluation of COVID-19 main protease inhibitor","volume":"59","author":"Nepolraj","year":"2021","journal-title":"Vietnam J. Chem."},{"key":"10.1016\/j.bpc.2026.107638_bb0120","series-title":"Version 5.0","author":"STATITCF Software","year":"1987"},{"key":"10.1016\/j.bpc.2026.107638_bb0125","first-page":"61","article-title":"Structure activity and prediction of biological activities of compound (2-methyl-6-phenylethynylpyridine) derivatives relationships rely on electronic and topological descriptors","volume":"4","author":"Hmamouchi","year":"2014","journal-title":"J. Comput. Methods Mol. Des."},{"key":"10.1016\/j.bpc.2026.107638_bb0130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0169-7439(87)80084-9","article-title":"Principal component analysis","volume":"2","author":"Wold","year":"1987","journal-title":"Chemom. Intell. Lab. Syst."},{"key":"10.1016\/j.bpc.2026.107638_bb0135","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-1-62703-658-0_11","article-title":"Principal component analysis: a method for determining the essential dynamics of proteins","volume":"1084","author":"David","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bpc.2026.107638_bb0140","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1093-3263(01)00123-1","article-title":"Beware of q2","volume":"20","author":"Golbraikh","year":"2002","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.bpc.2026.107638_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemolab.2021.104266","article-title":"QSAR study of unsymmetrical aromatic disulfides as potent avian SARS-CoV main protease inhibitors using quantum chemical descriptors and statistical methods","volume":"210","author":"Chtita","year":"2021","journal-title":"Chemom. Intell. Lab. Syst."},{"key":"10.1016\/j.bpc.2026.107638_bb0150","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/qsar.200610151","article-title":"Principles of QSAR models validation: internal and external","volume":"26","author":"Gramatica","year":"2007","journal-title":"QSAR Comb. Sci."},{"key":"10.1016\/j.bpc.2026.107638_bb0155","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/026119290503300209","article-title":"Current status of methods for defining the applicability domain of (quantitative) structure-activity relationships","volume":"33","author":"Netzeva","year":"2005","journal-title":"Altern. Lab. Anim"},{"key":"10.1016\/j.bpc.2026.107638_bb0160","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1134\/S1070428021040126","article-title":"Synthesis and in silico study of 4-substituted 1-aminoanthraquinones","volume":"57","author":"Shupeniuk","year":"2021","journal-title":"Russ. J. Org. Chem."},{"key":"10.1016\/j.bpc.2026.107638_bb0165","doi-asserted-by":"crossref","first-page":"471","DOI":"10.18596\/jotcsa.703026","article-title":"Design of novel benzimidazole derivatives as potential \u03b1-amylase inhibitors by 3D-QSAR modeling and molecular docking studies","volume":"7","author":"El Khatabi","year":"2020","journal-title":"J. Turk. Chem. Soc. Sect. A"},{"key":"10.1016\/j.bpc.2026.107638_bb0170","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1016\/j.bmc.2003.11.037","article-title":"QSAR and ADME","volume":"12","author":"Hansch","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bpc.2026.107638_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2020.107241","article-title":"Structure-based virtual screening of influenza virus RNA polymerase inhibitors from natural compounds: molecular dynamics simulation and MM-GBSA calculation","volume":"85","author":"Jin","year":"2020","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.bpc.2026.107638_bb0180","first-page":"8","article-title":"Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions","volume":"1","author":"Ertl","year":"2009","journal-title":"J. Chemother."},{"key":"10.1016\/j.bpc.2026.107638_bb0185","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bpc.2026.107638_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e06603","article-title":"Prediction of potential inhibitors of SARS-CoV-2 using 3D-QSAR, molecular docking modeling and ADMET properties","volume":"7","author":"Khaldan","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/j.bpc.2026.107638_bb0195","first-page":"527","article-title":"Combined 3D-QSAR modeling and molecular docking study on metronidazole triazole styryl hybrids as antiamoebic activity","volume":"8","author":"Khaldan","year":"2020","journal-title":"Moroccan J. Chem."},{"key":"10.1016\/j.bpc.2026.107638_bb0200","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.3390\/plants12193376","article-title":"Phytochemical composition and pharmacological activities of three essential oils collected from eastern Morocco (Origanum compactum, Salvia officinalis, and Syzygium aromaticum): a comparative study","volume":"12","author":"Loukili","year":"2023","journal-title":"Plants"},{"key":"10.1016\/j.bpc.2026.107638_bb0205","article-title":"Structure-based design and computational evaluation of tamoxifen derivatives as estrogen receptor antagonists against breast cancer","volume":"30","author":"Lahyaoui","year":"2025","journal-title":"Sci. Afr."},{"key":"10.1016\/j.bpc.2026.107638_bb0210","article-title":"An integrated computational approach combining QSAR modeling, molecular docking, and ADME profiling for the discovery of selective CYP11B1 inhibitors","volume":"31","author":"El Yaqoubi","year":"2026","journal-title":"Sci. Afr."},{"key":"10.1016\/j.bpc.2026.107638_bb0215","doi-asserted-by":"crossref","first-page":"100959","DOI":"10.1016\/j.chphi.2025.100959","article-title":"Design, quantitative structure\u2013activity relationships and computational studies of Acylshikonin derivatives: insights into antitumor activity","volume":"11","author":"Lahyaoui","year":"2025","journal-title":"Chem. Phys. Impact"},{"key":"10.1016\/j.bpc.2026.107638_bb0220","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1021\/jm100112j","article-title":"A medicinal chemist's guide to molecular interactions","volume":"53","author":"Bissantz","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bpc.2026.107638_bb0225","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nrd1549","article-title":"Docking and scoring in virtual screening for drug discovery: methods and applications","volume":"3","author":"Kitchen","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bpc.2026.107638_bb0230","first-page":"9","article-title":"QSAR study of \u03b1-glucosidase inhibitors for benzimidazole bearing bis-Schiff bases using CoMFA, CoMSIA, and molecular docking","volume":"6","author":"Khaldan","year":"2021","journal-title":"Int. J. Quant. Struct. Prop. Relat."},{"key":"10.1016\/j.bpc.2026.107638_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e07463","article-title":"QSAR, molecular docking and ADMET properties in silico studies of novel 4,5,6,7-tetrahydrobenzo[D]thiazol-2-yl derivatives derived from dimedone as potent anti-tumor agents through inhibition of C-met receptor tyrosine kinase","volume":"7","author":"Daoui","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/j.bpc.2026.107638_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e13020","article-title":"QSAR modeling and molecular docking studies of 2-oxo-1,2-dihydroquinoline-4-carboxylic acid derivatives as p-glycoprotein inhibitors for combating cancer multidrug resistance","volume":"9","author":"Lahyaoui","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.bpc.2026.107638_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2023.104783","article-title":"QSAR modeling, molecular docking and molecular dynamic simulation of phosphorus-substituted quinoline derivatives as topoisomerase i inhibitors","volume":"16","author":"Lahyaoui","year":"2023","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.bpc.2026.107638_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2024.101410","article-title":"Novel 1,2,3-triazolic compounds derived from cytosine: synthesis, spectroscopic characterization, in vitro antimicrobial activity and molecular docking studies","volume":"7","author":"Lahyaoui","year":"2024","journal-title":"Results Chem."},{"key":"10.1016\/j.bpc.2026.107638_bb0255","first-page":"168","article-title":"Amino-modified perillyl alcohol derivatives: QSAR modeling, drug-likeness characteristics and molecular docking investigations as an activation of apoptosis to tumor cells","volume":"13","author":"Lahyaoui","year":"2025","journal-title":"Moroccan J. Chem."},{"key":"10.1016\/j.bpc.2026.107638_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2024.101699","article-title":"Development of novel antibiotics derived from pyridazine: synthesis, spectroscopic characterization, in vitro antimicrobial activity and molecular docking studies","volume":"10","author":"Lahyaoui","year":"2024","journal-title":"Results Chem."},{"key":"10.1016\/j.bpc.2026.107638_bb0265","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.3390\/molecules29163855","article-title":"An investigation of novel series of 2-thioxo-1,3-dithiol-carboxamides as potential antispasmodic agents: design, synthesis via coupling reactions, density functional theory calculations, and molecular docking","volume":"29","author":"Sghyar","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bpc.2026.107638_bb0270","first-page":"1367","article-title":"Novel triazole-pyrazine as potential antibacterial agents: synthesis, characterization, antibacterial activity, drug-likeness properties and molecular docking studies","volume":"12","author":"Filali","year":"2024","journal-title":"Moroccan J. Chem."},{"key":"10.1016\/j.bpc.2026.107638_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138747","article-title":"Newly synthesized based Schiff of phenylferrocene: molecular and crystal structures, density functional theory calculations, Hirshfeld surface analyses, and improved molecular docking data","volume":"1314","author":"Sghyar","year":"2024","journal-title":"J. Mol. Struct."},{"issue":"2","key":"10.1016\/j.bpc.2026.107638_bb0280","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1021\/acsomega.4c08773","article-title":"Novel d-ribofuranosyl tetrazoles: synthesis, characterization, in vitro antimicrobial activity, and computational studies","volume":"10","author":"Sghyar","year":"2025","journal-title":"ACS Omega"},{"issue":"3","key":"10.1016\/j.bpc.2026.107638_bb0285","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/biom9030082","article-title":"Structural determinants of isoform selectivity in PI3K inhibitors","volume":"9","author":"Miller","year":"2019","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.bpc.2026.107638_bb0290","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.drudis.2015.07.008","article-title":"Small-molecule kinase inhibitors: an analysis of FDA-approved drugs","volume":"21","author":"Wu","year":"2016","journal-title":"Drug Discov. Today"}],"container-title":["Biophysical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301462226000712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301462226000712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:47:01Z","timestamp":1779346021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301462226000712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":58,"alternative-id":["S0301462226000712"],"URL":"https:\/\/doi.org\/10.1016\/j.bpc.2026.107638","relation":{},"ISSN":["0301-4622"],"issn-type":[{"value":"0301-4622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico QSAR-guided design of Dammarane-type triterpenoids as potential PI3K\u03b1-targeted anticancer agents","name":"articletitle","label":"Article Title"},{"value":"Biophysical Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpc.2026.107638","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107638"}}